Company Evogene Ltd TEL AVIV STOCK EXCHANGE
Equities
IL0011050551
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Agriculture
67.2
%
| 1 | 52.3 % | 4 | 67.2 % | +332.76% |
Industrial Applications
19.1
%
| 0 | 4.3 % | 1 | 19.1 % | +1,393.06% |
Human Health
8.6
%
| 1 | 30.6 % | 0 | 8.6 % | -5.07% |
Unallocated
5.1
%
| 0 | 12.8 % | 0 | 5.1 % | +34.11% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
65.0
%
| 1 | 51.0 % | 4 | 65.0 % | +329.15% |
Others
19.0
%
| 0 | 4.0 % | 1 | 19.0 % | +1,499.40% |
Israel
16.0
%
| 1 | 45.0 % | 1 | 16.0 % | +19.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-12-31 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 22-03-31 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 04-12-31 |
Eyal Ronen
PRN | Corporate Officer/Principal | - | 22-05-31 |
Sassi Masliah
PRN | Corporate Officer/Principal | - | 10-12-31 |
Human Resources Officer | - | 14-12-31 | |
Nir Arbel
PRN | Corporate Officer/Principal | - | 21-07-31 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 21-11-16 |
Sarit Firon
CHM | Chairman | 58 | 16-08-10 |
Leon Recanati
BRD | Director/Board Member | 76 | 05-04-30 |
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-12-31 |
Oded Shoseyov
BRD | Director/Board Member | 67 | 18-10-31 |
Nir Nimrodi
BRD | Director/Board Member | 55 | 22-08-31 |
Adrian Percy
BRD | Director/Board Member | 59 | 19-02-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,584,888 | 49,746,029 ( 98.34 %) | 0 | 98.34 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |